Exodus Point Capital Management, LP Meridian Bioscience Inc Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$19.76 - $29.89 $271,206 - $410,240	-13,725 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $215,894 - $297,283	13,725 New	13,725 $257,000
Q3 2020 Nov 16, 2020	SELL	$13.54 - $26.41 $677,961 - $1.32 Million	-50,071 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $281,236 - $835,458	35,872 Added 252.64%	50,071 $1.17 Million
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $79,088 - $163,288	14,199 New	14,199 $119,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.